GHCM
BHVN

Glen Harbor Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Glen Harbor Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$73K Hold
1,744
– – ﹤0.01% 1209
2019
Q2 		$76K Buy
1,744
+1,088
+166% +$61.3K ﹤0.01% 1213
2019
Q1 		$34K Hold
656
– – ﹤0.01% 1247
2018
Q4 		$24K Buy
+656
New +$23.7K ﹤0.01% 1225

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Glen Harbor Capital Management's BHVN Position: Q3 2019 in Review

Glen Harbor Capital Management held its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) position steady in Q3 2019 at 1,744 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Glen Harbor Capital Management first reported a position in BHVN in Q4 2018 and has held it in 4 quarters since. The position peaked at $76K in Q2 2019. 184 funds tracked by Wall St. Rank hold BHVN as of Q3 2019.

  • Glen Harbor Capital Management held 1,744 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $73K as of Q3 2019.
  • Glen Harbor Capital Management left its Biohaven Pharmaceutical Holding Company Ltd. share count unchanged in Q3 2019.
  • Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1209 holding.
  • Glen Harbor Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and has held it in 4 quarters since.
  • Glen Harbor Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $76K in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.